Advertisement

Topics

Latest Stem Cells NewsRSS

02:31 EST 24th January 2019 | BioPortfolio

. @ruhrunibochum scientists eye overexpression of muscle LIM protein as a potential therapeutic strategy for promoting the repair of nerves in the #brain, the optic nerve, and the spinal cord: http://ow.ly/s1X330nqex4 

. @ruhrunibochum scientists eye overexpression of muscle LIM protein as a potential therapeutic strategy for promoting the repair of nerves in the #brain, the optic nerve, and the spinal cord: http://ow.ly/s1X330nqex4 

Targeted Treatment Shrinks Deadly Pediatric Brain Tumors

NewsChemotherapy and radiation are effective cancer treatments because they kill rapidly dividing cells, including tumor cells. But for children--whose tiny bodies are still growing--these treatments can cause lifelong damage.

Vedanta Biosciences Announces Publication in Nature of Seminal Research Revealing A New Mechanism of Human Microbiota-Driven Antitumor Immunity Involving Induction of IFNy+ CD8+ T Cell Accumulation in the Gut and Tumors

Research also identified a rationally-defined consortium of human commensal bacteria (VE800) that robustly induces IFNy+ CD8+ T cells and enhances antitumor immunity Vedanta’s clinical candidate VE800 is expected to enter clinical studies in 2019 in combination with Bristol-Myers Squibb’s checkpoint inhibitor OPDIVO® (nivolumab)

Hematopoietic stem cell transplantation reduces transcranial doppler velocities in children with sickle cell anemia

1. In this nonrandomized controlled intervention study, matched sibling donor stem cell transplantation (MSD-HSCT) was associated with lower transcranial doppler velocities (TCDs) at 1 year compared to chronic transfusions. 2. MSD-HSCT was also associated with changes in highest TCDs at 3 years, normalization rate at 1 year, and ferritin levels at 1 and 3 years. […] Source: 2 Minute Med...

Nerve Regeneration Pumped Up by Muscle Protein

Nerves of the central nervous system may begin flexing regenerative powers if they can be induced to express a protein normally found in muscle cells. These nerves won’t even have to submit to any grueling exercise routines. Instead, they may benefit from gene therapy, a new study suggests. According to a team of scientists based […] The post Nerve Regeneration Pumped Up by Muscle Protein ...

Pain Specialist Dr. Jason Arora with Atlantic Spine Center Offers Tips to Prevent Peripheral Joint Problems

Treating joint disorders may truly come from within. WEST ORANGE, N.J. (PRWEB) January 23, 2019 “Everyone has a doctor within them.” Those words -- from ancient Greek physician Hippocrates -- are proving increasingly true as physicians learn more about using a patient’s own cells effectively to treat peripheral joint pain and disorders that disable millions of Americans, says interventional...

Eaze Releases 2018 Data Report on California Cannabis Trends

Data Report Shows An Upward Trend Among Females, Baby Boomers and CBD for Wellness Eaze, a cannabis marketplace, today released its fourth annual Eaze Insights: 2018 State of Cannabis data report, a comprehensive overview of consumer trends driving the cannabis industry year over year. The report draws insights f

Global Sickle Cell Disease Treatment Market 2019-2023 | Advent of Regenerative Therapy to Drive Growth | Technavio

The global sickle cell disease treatment market research report by Technavio predicts the market to post a CAGR of more than 11% during the period 2019-2023. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190123005

Genprex to Present at NobleConXV in Fort Lauderdale, Florida

Noble Capital Markets' Fifteenth Annual Investor / Equity Conference Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, today announced that its President and Chief Operating Officer, Julien Pham, MD, MPH, will deliver a presentation about ...

InGeneron Expands Development Pipeline with Two Osteoarthritis Programs

Company enrolls first patients in feasibility studies for chronic back pain and wrist osteoarthritis, setting clinical development focus on orthopedic indications InGeneron, Inc., a regenerative medicine and cell therapy company, announced today the enrollment of the first patients in two new feasibility studies evaluating InGeneron’s regenerative ce...

Dr. Yong-Beom Park’s Research in Cartilage Regeneration Earns Him Young Investigator Award

Yong-Beom Park, M.D., Ph.D., is named the STEM CELLS Translational Medicine’s Young Investigator of 2018 for his research in cartilage regeneration in osteoarthritic patients. DURHAM, N.C. (PRWEB) January 23, 2019 Yong-Beom Park, M.D., Ph.D., is named the STEM CELLS Translational Medicine’s Young Investigator of 2018 for his research in cartilage regeneration in osteoarthritic patients. The a...

STEMCELL Technologies Launches mTeSR™ Plus, a Next-Generation Culture System for Human ES and iPS Cell Maintenance

STEMCELL Technologies has released mTeSR™ Plus, an enhanced version of mTeSR™1, the most widely published

PCI Advanced Therapeutic Medicinal Products (ATMPs)

PCI provides pharmaceutical service solutions for a range of therapies including gene therapies, somatic cell therapies (stem cells) and tissue engineered products also known as Advanced Therapeutic Medicinal Products (ATMPs).

First human stem cell-derived product candidate implanted in type 1 diabetes patients in Europe

Type 1 diabetes is the major form of diabetes diagnosed under age 40 where patients with this disease can no longer produce insulin. The stem-cell derived product candidate The post First human stem cell-derived product candidate implanted in type 1 diabetes patients in Europe appeared first on Compelo Medical Devices.

Propanc’s Cancer Stem Cell Technology Ready for the Clinic

James Nathanielsz, CEO of Propanc Biopharma, talks about preclinical development, funding, cancer stem cells and more. The post Propanc’s Cancer Stem Cell Technology Ready for the Clinic appeared first on Investing News Network.

Blinatumomab Approved in Europe for MRD+ ALL

The European Commission has approved blinatumomab for the treatment of adult patients with B-cell precursor acute lymphoblastic leukemia who are in remission but still have minimal residual disease of at least 0.1%.

FDA Grants Umbralisib Breakthrough Designation for Marginal Zone Lymphoma

The FDA has granted umbralisib (TGR-1202) a breakthrough therapy designation for the treatment of adult patients with marginal zone lymphoma who have received 1 prior anti-CD20 regimen.

Gamida Cell and Be The Match BioTherapies Announce Strategic Collaboration

Gamida Cell (Nasdaq:GMDA), a leading cellular and immune therapeutics company, and Be The Match BioTherapies, a subsidiary of the National Marrow Donor Program®/Be The Match® offering integrated platforms and software to manage the collection and delivery of cellular therapies, today announced a strategic collaboration to improve outcomes for patients undergoing allogeneic hematopoietic stem ...

BrainStorm Granted Additional Patent for NurOwn in Israel

BrainStorm Cell Therapeutics (NASDAQ:BCLI), a leader in developing innovative autologous cellular therapies for debilitating neurodegenerative diseases, today announced that the Israel Patent Office has granted an additional patent titled “Methods of Generating Mesenchymal Stem Cells which Secrete Neurotrophic Factors.” As quoted in the press release: The allowed claims cover the method of man...

Health care consulting firm Vynamic opens new office in London

With offices in Philadelphia and Boston, Vynamicâs London office â co-located with STEM Healthcare â is the companyâs first outside the US as it looks to support existing and new clients globally.

Physicians’ Education Resource® to Present Optimizing Outcomes Through Stem Cell Mobilization as a Satellite Symposium Adjunct to the Transplantation and Cellular Therapy Meetings (TCT)

Key experts will explore the latest updates and insights in the treatment of multiple myeloma and non-Hodgkin lymphoma Physicians’ Education Resource® (PER®), a leading resource for continuing medical education (CME), will host a CME-accredited activity, Optimizing Outcomes Through Stem Cell Mobilization: Applying Evidence to Patients With Multiple...

PharmaCyte Biotech Releases CEO Interview from The Big Biz Show

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature

VetStem Biopharma is Pleased to Announce Dr. Douglas Stramel of Advanced Care Veterinary Services is Successfully Using the Pall V-PET™ Platelet Therapy System

Dr. Douglas Stramel of Advanced Care Veterinary Services has been using Veterinary Platelet Enhancement Therapy (V-PET™) since 2016. Pinky, a Great Dane with a torn cruciate ligament, is among his patients who have had a favorable response to the therapy. POWAY, Calif. (PRWEB) January 22, 2019 Dr. Douglas Stramel of Advanced Care Veterinary Services in Carrollton, Texas has been using the Pall...

Gamida Cell and Be The Match BioTherapies® Announce Strategic Collaboration

– Collaboration Aims to Expand the Use of Bone Marrow Transplant to Treat Hematologic Malignancies and Serious Blood Disorders – Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, and

AgeX Therapeutics’ CEO Dr. Michael D. West Presents at Precision Medicine World Conference 2019

AgeX Therapeutics, Inc. (NYSE American: AGE), a biotechnology company focused on developing and commercializing innovative therapeutics for human aging, announced today that Founder and CEO Michael D. West, Ph.D. presented at Precision Medicine World Conference 2019, January 21 in Sili

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Stem Cells market research data and corporate reports here